{"disease":{"id":"eyelash-hypotrichosis","name":"eyelash hypotrichosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02505776","title":"Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":1699,"lead_sponsor_name":"Allergan","has_results":false},{"nct_id":"NCT01623479","title":"An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes","phase":"","overall_status":"COMPLETED","enrollment_count":585,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT01391273","title":"Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT01023841","title":"Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT01391286","title":"Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Allergan","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}